XML 101 R83.htm IDEA: XBRL DOCUMENT v3.7.0.1
FINANCIAL INFORMATION OF PARENT COMPANY (Condensed Statement of Cash Flows) (Details)
¥ in Thousands, $ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2011
USD ($)
Dec. 31, 2016
CNY (¥)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
CNY (¥)
Dec. 31, 2014
CNY (¥)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Exchange (gain) loss   ¥ (320) $ (46) ¥ 124 ¥ 2,650
Changes in liabilities, net of effects of acquisition:          
Changes in other current liabilities   (19,043) (2,742) 82,533 15,993
Net cash provided by (used in) operating activities   13,441 1,936 2,202 (66,488)
Cash flows from investing activities:          
Investment in cost method investees   (6,750) (972) (7,682)
Net cash used in investing activities   (119,429) (17,202) (126,949) (30,545)
Cash flows from financing activities:          
Proceeds from amounts due to related parties   68,941
Repayment of amounts due to related parties   (61,472)
Proceeds from shareholders’ payment for ordinary shares   17
Proceeds from issuance of Series D convertible redeemable preferred shares, net   145,746
Proceeds from issuance of ordinary shares upon public offering   253,678 36,537 784,350
Proceeds from exercises of stock options   3,943 568 161
Payment for ordinary shares repurchase   (45,321) (6,528) (13,958)
Advances for ordinary shares repurchase   (5,521)
Payment for public offering costs   (15,644) (2,253) (77,289) (2,128)
Net cash provided by financing activities   210,719 30,350 687,743 151,104
Net increase in cash and cash equivalents   104,731 15,084 562,996 54,071
Cash and cash equivalents, beginning of year   787,257 113,389 206,391 154,156
Effect of exchange rate changes on cash and cash equivalents   25,331 3,648 17,870 (1,836)
Cash and cash equivalents, end of year   917,319 132,121 787,257 206,391
Parent Company [Member]          
Cash flows from operating activities:          
Net income (loss)   86,633 12,477 22,621 (59,814)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Exchange (gain) loss   (7) (1) 471 2,414
Equity in (income) loss of subsidiaries and VIE   (86,951) (12,523) (23,644) 57,334
Changes in liabilities, net of effects of acquisition:          
Changes in other current liabilities   (6,394) (921) 9,127 38
Net cash provided by (used in) operating activities   (6,719) (968) 8,575 (28)
Cash flows from investing activities:          
Advances to subsidiaries and VIE   (14,879) (2,143) (229,031) (5,932)
Investment in cost method investees   (6,682)
Investments in subsidiaries   14,139 2,037 (366,234)
Net cash used in investing activities   (740) (106) (601,947) (5,932)
Cash flows from financing activities:          
Proceeds from amounts due to related parties   68,941
Repayment of amounts due to related parties   (61,472)
Proceeds from shareholders’ payment for ordinary shares   17
Proceeds from issuance of Series D convertible redeemable preferred shares, net   145,746
Proceeds from issuance of ordinary shares upon public offering   253,678 36,537 784,350
Proceeds from exercises of stock options   3,943 568 11
Payment for ordinary shares repurchase   (45,321) (6,528) (13,958)
Advances for ordinary shares repurchase   (5,521)
Payment for public offering costs   (15,644) (2,253) (77,289) (823)
Net cash provided by financing activities   196,656 28,324 687,593 152,409
Net increase in cash and cash equivalents   189,197 27,250 94,221 146,449
Cash and cash equivalents, beginning of year   254,213 36,614 144,814
Effect of exchange rate changes on cash and cash equivalents   17,260 2,486 15,178 (1,635)
Cash and cash equivalents, end of year   ¥ 460,670 $ 66,350 ¥ 254,213 ¥ 144,814